By: Seth Augenstein From: cancernetwork.com The promise of immunotherapy in fighting cancer is limited by finding the right targets for each patient. What works for one person’s biology is often useless in another’s. Selecting the mutations using an algorithm is a new model which a University of Pennsylvania team says could make. The open-source tool called “antigen.garnish,” introduced in the journal Cell …
Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study
Source: National Comprehensive Cancer Network From: prnewswire.com Research from the O’Neal Comprehensive Cancer Center at UAB finds patients treated outside of NCCN Guidelines recommendations had significantly higher direct costs A new study from the O’Neal Comprehensive Cancer Center at University of Alabama at Birmingham (UAB), published in the October 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, finds …
Foreign-born women lagging behind US peers in breast cancer screening rates
By: Marty Stempniak From: radiologybusiness.com Breast is the leading cancer killer for Hispanic women in the U.S., and it ranks second among white, black and Asian populations. Incidence of the disease and receipt of crucial mammography screening are often impacted by whether a woman was born in a foreign country, which can snowball into disparities in treatment outcomes. There’s been …
HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections
By: NCI Staff From: cancer.gov The potential benefits of vaccines are twofold: In addition to directly protecting those who get the vaccine, they also protect those who don’t. The latter, a phenomenon called herd immunity, occurs only if enough people get vaccinated that the disease-causing germ can’t spread easily. Now a new study suggests that the human papillomavirus (HPV) vaccine …
Metastatic Breast Cancer: What You Should Know
By: Rene Wisely From: uofmhealth.org What does it mean to have metastatic, or stage 4, breast cancer? A Rogel Cancer Center oncologist explains the diagnosis and how it’s treated. After hearing a diagnosis of metastatic breast cancer, a rush of questions emerges. But often, it’s not until long after leaving the doctor’s office. Metastatic means the cancer has spread beyond …
West Cancer Center is the first center in the country to offer the first FDA-approved Mesothelioma treatment in more than 15 years
A clinical study showed that the NovoTTF-100L™ System in combination with chemotherapy may help people with malignant pleural mesothelioma extend their lives West Cancer Center is pleased to announce they have been designated as the first center in the country approved to prescribe NovoTTF-100L for the treatment of malignant pleural mesothelioma (MPM). Experts at West Cancer Center are now certified …
Lung Cancer Studies From TRACERx Consortium Explore How Tumor Cells Evolve
By: Staff Reporter From: genomeweb.com Blood and tumor samples might be able to differentiate lung cancer patients whose disease is likely to spread from those who won’t progress, according to three new studies. More than 218,000 people are diagnosed with lung cancer each year in the US, and less than a fifth of patients survive for more than five years. …
Patient Selection Key When De-Escalating Radiation in Breast Cancer
By: Danielle Ternyila From: onclive.com Over the past several years, several clinical trials have evaluated the role of radiation in the treatment of patients with breast cancer and whether doses can be reduced. Although de-escalation is possible, patient selection is key, according to Jonathan B. Strauss, MD, MBA. “Selecting the right patients for de-escalation is key. Right now, we are …
Inflammatory Breast Cancer Has Diagnostic Challenges, Requires More Awareness
By: Danielle Ternyila From: onclive.com Inflammatory breast cancer (IBC) is commonly misdiagnosed because it is a rare form of breast cancer that many oncologists do not see frequently. Several institutions in the United States have special clinics for IBC, such as The University of Texas MD Anderson Cancer Center, giving patients access to clinical trials, as well as physicians who …
Use of Neoadjuvant Endocrine Therapy Showcases Testing Capabilities in Breast Cancer
By: Darcy Lewis From: onclive.com In breast cancer, neoadjuvant endocrine therapy shows promise in a variety of areas, including as an excellent testing platform, Ingrid A. Mayer, MD, MSCI, said in a presentation during the 2019 Lynn Sage Breast Cancer Symposium.1 Neoadjuvant endocrine therapy allows clinicians to determine resistance mechanisms to endocrine therapy with or without targeted agents. It also …